Literature DB >> 26202478

Genetic polymorphism of miR-146a is associated with gastric cancer risk: a meta-analysis.

Y Sun1, M Li2.   

Abstract

Several studies have investigated the associations between miR-146a rs2910164 and gastric cancer (GC) risk, but results have been inconclusive. To derive a more precise estimation of the relationship, a meta-analysis was performed. PubMed and China National Knowledge Infrastructure searches were carried out for relevant studies published before July 2014. Meta-analysis was performed with the stata, version 11.0. A total of seven case-control studies, including 3283 cases and 4535 controls, were selected. A significant association was found between rs2910164 and GC risk under all genetic models (CC vs. GG, OR = 0.76, 95% CI = 0.66-0.87; CC vs. GC+GG, OR = 0.84, 95% CI = 0.71-0.99; CC+GC vs. GG, OR = 0.82, 95% CI = 0.73-0.91) for the total data. In the subgroup analysis by ethnicity, statistically significant association was found in Asian. This meta-analysis suggested that the miR-146a rs2910164 was a risk factor for developing GC.
© 2015 John Wiley & Sons Ltd.

Entities:  

Keywords:  gastric cancer; meta-analysis; miR-146a; polymorphism

Mesh:

Substances:

Year:  2015        PMID: 26202478     DOI: 10.1111/ecc.12355

Source DB:  PubMed          Journal:  Eur J Cancer Care (Engl)        ISSN: 0961-5423            Impact factor:   2.520


  2 in total

Review 1.  Association between miR-146a rs2910164 polymorphism and specific cancer susceptibility: an updated meta-analysis.

Authors:  Xia Hao; Lingzi Xia; Ruoyi Qu; Xianglin Yang; Min Jiang; Baosen Zhou
Journal:  Fam Cancer       Date:  2018-07       Impact factor: 2.375

2.  miRNA-146a rs2910164 C>G polymorphism increased the risk of esophagogastric junction adenocarcinoma: a case-control study involving 2,740 participants.

Authors:  Yu Chen; Weifeng Tang; Chao Liu; Jing Lin; Yafeng Wang; Sheng Zhang; Gang Chen; Xiongwei Zheng
Journal:  Cancer Manag Res       Date:  2018-06-25       Impact factor: 3.989

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.